Please login to the form below

Not currently logged in
Email:
Password:

onartuzumab

This page shows the latest onartuzumab news and features for those working in and with pharma, biotech and healthcare.

Deaths cause Amgen to drop stomach cancer drug

Deaths cause Amgen to drop stomach cancer drug

Another drug acting via the HGF/SF:MET pathway - Roche/Genentech's onartuzumab - suffered a setback earlier this year although in this case the problem was a lack of efficacy in

Latest news

  • Roche drug fails in lung cancer trial Roche drug fails in lung cancer trial

    Damages prospects for onartuzumab. A phase III trial of Roche's cancer prospect onartuzumab has been abandoned after the drug failed to show efficacy. ... In a statement, Roche said it is evaluating the implications of the METLung study results across

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Mednet Group

Communique Small consultancy of the year 2020. With diversity and inclusion at our core, Mednet Group consists of Attigo CIC...

Latest intelligence

How nature can help you manage the pressures of agency life
Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....